1. Home
  2. HITI vs CCCC Comparison

HITI vs CCCC Comparison

Compare HITI & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo High Tide Inc.

HITI

High Tide Inc.

HOLD

Current Price

$2.43

Market Cap

213.6M

Sector

N/A

ML Signal

HOLD

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$3.54

Market Cap

185.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HITI
CCCC
Founded
2009
2015
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
213.6M
185.1M
IPO Year
2021
2020

Fundamental Metrics

Financial Performance
Metric
HITI
CCCC
Price
$2.43
$3.54
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
6
Target Price
$6.13
$12.20
AVG Volume (30 Days)
406.7K
2.8M
Earning Date
06-15-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
16.45
EPS
N/A
N/A
Revenue
N/A
$35,947,000.00
Revenue This Year
$23.73
N/A
Revenue Next Year
$12.80
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1.02
52 Week Low
$2.10
$1.21
52 Week High
$4.06
$3.95

Technical Indicators

Market Signals
Indicator
HITI
CCCC
Relative Strength Index (RSI) 49.66 65.54
Support Level $2.36 $2.37
Resistance Level $2.69 $3.82
Average True Range (ATR) 0.09 0.30
MACD -0.01 0.07
Stochastic Oscillator 34.00 70.63

Price Performance

Historical Comparison
HITI
CCCC

About HITI High Tide Inc.

High Tide Inc is a downstream-focused retailer of cannabis products, distributor, and seller of smoking accessories and cannabis lifestyle products. It is a vertically integrated company in the Canadian cannabis market with various brands in its portfolio such as Canna Cabana, Fastendr, Queen of Bud, Grasscity, Daily High Club, and others. The company's reportable operating segments are: Bricks and mortar, which generates maximum revenue, and E-commerce. Geographically, it derives maximum revenue from its business in Canada, followed by the United States of America, and other international markets.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Share on Social Networks: